Oregon Cancer

News and information for cancer services throughout Oregon.

  • Recognizing the important contributions of oncology APPs

    Recognizing the important contributions of oncology APPs

    Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.

    Read Article
  • New division director and deputy director of Hematology and Medical Oncology share a vision

    New division director and deputy director of Hematology and Medical Oncology share a vision

    Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.

    Read Article
  • New study aims to fill treatment gap for patients with endometrial cancer

    New study aims to fill treatment gap for patients with endometrial cancer

    For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.

    Read Article
  • Two trials evaluate new approaches to treating non-Hodgkin and follicular lymphomas

    Two trials evaluate new approaches to treating non-Hodgkin and follicular lymphomas

    New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.

    Read Article
  • Two new trials enrolling patients with rectal cancer and solid tumors

    Two new trials enrolling patients with rectal cancer and solid tumors

    A phase II trial tests FOLFOX or CAPOX versus FOLFIRINOX in patients with locally advanced rectal cancer, and a phase I trial evaluates TBio-4101 in patients with advanced solid tumors.

    Read Article
  • Promising results of Providence-sponsored trial published in npj Breast Cancer

    Promising results of Providence-sponsored trial published in npj Breast Cancer

    Final outcomes from a Providence Cancer Institute-sponsored phase Ib trial evaluating pembrolizumab with either weekly paclitaxel or flat-dose capecitabine in treating patients with metastatic TNBC.

    Read Article
  • Providence researchers contribute to more than 20 studies presented at ASCO Annual Meeting

    Providence researchers contribute to more than 20 studies presented at ASCO Annual Meeting

    Researchers from Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, shared their investigations to advance cancer research and treatments at the premier event.

    Read Article
  • Breast cancer survivor, artist gives back to Providence

    Breast cancer survivor, artist gives back to Providence

    Portland painter credits the support of Providence providers and creating art for helping her recover and heal from breast cancer and the loss of her mother.

    Read Article
  • Providence cancer experts offer free educational talks

    Providence cancer experts offer free educational talks

    Virtual talks at Providence highlight MRI-guided radiation therapy for treating breast cancer, pancreatic cancer treatments, and sexual health during and after ovarian cancer.

    Read Article
  • Immunotherapies evaluated in new trials for AML, melanoma and solid tumor cancers

    Immunotherapies evaluated in new trials for AML, melanoma and solid tumor cancers

    New investigator-initiated trial at Providence to evaluate a triple combination of medications for treating melanoma, and two new studies evaluating medication combinations to treat AML.

    Read Article
  • Prestigious grant awarded to Providence researcher

    Prestigious grant awarded to Providence researcher

    Providence researchers awarded an R21 grant from the National Institutes of Health which provides funding for projects with potential to significantly advance biomedical research.

    Read Article
  • Register for a free, virtual cancer nutrition class

    Register for a free, virtual cancer nutrition class

    A free virtual online class hosted by Providence Cancer Institute will highlight what to eat during cancer treatments, how to manage side effects and how to speed healing.

    Read Article
  • Get to know Dr. Sasha Stanton: Physician, scientist, first soprano

    Get to know Dr. Sasha Stanton: Physician, scientist, first soprano

    Physician scientist Sasha Stanton, M.D., Ph.D., shares her career journey to medical oncology and breast cancer research at Providence Cancer Institute.

    Read Article
  • Providence volunteer and cancer survivor offers patients hope and a smile   

    Providence volunteer and cancer survivor offers patients hope and a smile   

    Cancer survivor Jeff Newell shares his experiences as a volunteer at Providence Cancer Institute and how he uses his own cancer journey to impart hope to others.

    Read Article
  • Three studies highlight the range of our pioneering research

    Three studies highlight the range of our pioneering research

    Studies open at Providence Cancer Institute in Oregon for patients with head and neck cancer and patients with breast cancer that has metastasized in the brain.

    Read Article
  • Providence Willamette Falls celebrates opening of new cancer center

    Providence Willamette Falls celebrates opening of new cancer center

    World class cancer-care is coming even closer to home for Clackamas County residents. Providence Willamette Falls Medical Center is now serving patients at the Carol Daniel Suzuki Cancer Center.

    Read Article
  • Honoring our physicians on Doctors’ Day

    Honoring our physicians on Doctors’ Day

    In honor of Doctors' Day on March 30, we recognize the significant contributions of physicians and their commitment to providing the most advanced, highest quality care for our cancer patients.

    Read Article
  • Targeted therapies are the focus of new studies for colorectal and bile duct cancers

    Targeted therapies are the focus of new studies for colorectal and bile duct cancers

    New trials available at Earle A. Chiles Research Institute for patients with human epidermal growth factor receptor 2 positive (HER2+) colorectal cancer and patients with cholangiocarcinoma.

    Read Article
  • Celebrating our oncology social workers

    Celebrating our oncology social workers

    In honor of Social Work Month we recognize the incredible contributions of oncology social workers.

    Read Article
  • Cancer vaccine is focus of breast cancer study at Providence

    Cancer vaccine is focus of breast cancer study at Providence

    A new trial offered at Providence Cancer Institute is enrolling patients with early-stage HR-positive and HER2-negative breast cancer.

    Read Article
  • loading
    Loading More...